(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The Toronto-Dominion bank (NYSE: TD) for potential violations of the federal securities laws.
If you invested in TD Bank, you are encouraged to obtain additional information by visiting .
Why Did TD Bank's Stock Drop?
TD Bank is the 10th largest bank in the United States.
On October 10, 2024, TD Bank pleaded guilty to criminal money-laundering-related charges and agreed to pay more than $3 billion in fines to the U.S. Department of Justice, the Federal Reserve, the Comptroller of the Currency, and the Treasury Department's Financial Crimes Enforcement Network. The Comptroller of the Currency also imposed an“asset cap” that prevents TD Bank from growing any larger than its current size.
The news caused a significant decline in the price of TD Bank stock. On October 10, 2024, the price of the company's stock fell 6.4%, from a closing price of $63.51 per share on October 9, 2024, to $59.44 per share on October 10, 2024.
Click here for more information: .
What Can You Do?
If you invested in TD Bank you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
Or contact:
Ross Shikowitz
...
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit .
Attorney advertising. Past results do not guarantee future outcomes.
MENAFN21102024004107003653ID1108800919
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.